Press coverage
- Project HERCULES shows its strength for rare disease (RARE Revolution – Special edition February 2020)
- A watchdog group sets aside emotions to assess drugs’ value. Patients say their lives are more than a number (STAT News – August 2019)
- Charity’s war on disease uniting big pharma rivals (The Telegraph – February 2018)
- Pfizer and Roche among sponsors of HTA data-sharing initiative (The Pharma Letter – January 2018)
- Duchenne UK and pharma partner pilot data-sharing HTA approach (PMLiVE – January 2018)
- Pharma industry leaders join forces in support of DMD project, HERCULES (EPM Magazine – January 2018)
- Project Hercules to lead way in Duchenne muscular dystrophy (European Pharmaceutical Review – January 2018)
- Duchenne UK launches data-sharing initiative (BioCentury – January 2018)
- Pharma collaborates to improve chances of NICE backing Duchenne drugs (Pharmaphorum – January 2018)
- Duchenne UK launches data-sharing initiative (4-traders – January 2018)
- Pharmaceutical industry leaders join forces to pioneer novel approach to health technology assessment (Global Banking & Finance Review – January 2018)
- Pharma Giants Form UK-Based ‘Project Hercules’ to Generate Evidence for DMD Treatments (Muscular Dystrophy News – January 2018)
- Transforming access in rare diseases (PMLiVE – January 2018)
- New charity-industry initiative to pioneer novel approach to Health Technology Assessment (Drug Discovery Today – November 2017)
- New charity-industry initiative to pioneer novel approach to Health Technology Assessment (Medicalnewser.com – November 2017)
- Duchenne UK Collaborates with Industry to Speed Payer Value Assessment (Global Genes – November 2017)
- Charity-industry initiative launched focusing on DMD treatment (European Pharmaceutical Manufacturer (EPM) Magazine – November 2017)
- New initiative aims to improve chances of medicines receiving positive HTA decisions (Pharmacy Choice – November 2017)
- New initiative aims to improve chances of medicines receiving positive HTA decisions (News-medical.net – November 2017)
- Project HERCULES Aims to Help Britain’s Duchenne MD Patients Get New-therapy Coverage (Muscular Dystrophy News – November 2017)
Press releases
- Duchenne UK and Project HERCULES announce new patient centred quality of life tool
- Eight industry partners to support Phase 2 of Project HERCULES in 2019
- Project HERCULES awarded prestigious Rare Disease Award
- Duchenne UK launches Project HERCULES to help patients get faster access to potentially life-changing treatments
- Pharmaceutical industry leaders join forces to pioneer novel approach to Health Technology Assessment
- Project HERCULES in the media
- Duchenne UK’s Project HERCULES Awarded Prestigious Rare Disease Award
- Phase 2 of Project HERCULES